Clinical Trial Update: Lenalidomide and Dinutuximab With or Without Isotretinoin in Treating Younger Patients With Refractory or Recurrent Neuroblastoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial investigating lenalidomide and dinutuximab with or without isotretinoin in younger patients with refractory or recurrent neuroblastoma; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• Accutane (isotretinoin)
• Revlimid (lenalidomide)
• UNITUXIN (dinutuximab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Neuroblastoma, Refractory Neuroblastoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING